The Children’s Cardiomyopathy Foundation is seeking Letters of Intent from investigators for basic science, clinical, population-epidemiologic and translational research on cardiomyopathies affecting children age 18 and younger.
Deadline: June 14 (Letters of Intent).
Grants of up to $50,000 will be awarded to studies focused on the causes, diagnosis, or treatment of dilated, hypertrophic, restrictive, arrhythmogenic right ventricular, and left ventricular noncompaction cardiomyopathy. The grants are designed to provide seed funding to investigators for the testing of initial hypotheses and the collecting of preliminary data, with the goal of helping them secure long-term funding from the National Institutes of Health and other major granting institutions.
To be eligible, principal investigators must hold an M.D., Ph.D., or equivalent degree and reside in the United States or Canada. In addition, the PI must have a faculty appointment at an accredited U.S. or Canadian medical institution and have the ability to conduct independent research with publications in established peer-reviewed medical and scientific journals.
Info: https://goo.gl/YGyQae (NOFA).